Novedades
News
HeXemBio
Monday 26 de May de 2025
Pioneering cellular rejuvenation, HeXemBio developed the first regenerative therapy for hematopoietic stem cells, with transformative potential in transplant failure, aging, and longevity. Their platform is safe, scalable, and clinically disruptive.
Wednesday 21 de December de 2022
